| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0009 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.16 | 0.4 |